C4 Therapeutics’ Chief Medical Officer Sells 10,000 Shares Amid Rising Stock, Sparking Insider‑Trading Speculation
Insider sale by C4 Therapeutics’ chief medical officer shows routine portfolio rebalance, not a clear bet on the biotech’s near‑term outlook.
3 minutes to read